UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102 -

• click to rate

  Posted by Two Blokes Jun 12 - Filed in Stock - 6 views
  
  URGN Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESS Newswire / June 12, 2025 / A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd.